Literature DB >> 22083860

[Prognosis of surgically treated primary parotid gland cancer - an evaluation of 231 cases].

M Stenner1, C Molls, J-P Klussmann, K-B Hüttenbrink.   

Abstract

We present our results on the prognosis of parotid gland cancer with the help of a group of patients who were treated in a standardised manner and received a long term follow-up.We retrospectively analysed the clinicopathological data of 231 patients with a surgically treated primary parotid gland cancer and calculated survival parameters. The mean follow-up time was 52 months.The 5- and 10-year overall survival rate was 74.2% and 66.9%. 70 patients got a locoregional recurrence, 18.6% of those even after more than 5 years. Initial facial nerve palsy was a significant negative prognostic indicator for the disease-free survival. The most frequent histological subtypes could be divided into 3 prognostic groups with significant differences in the survival. The pathological tumour stage was a prognostic indicator for a worse overall and disease-free survival. The pT-stage, the pN-stage and the existence of distant metastases were independent prognostic factors.The group of patients is mainly characterised by the large size, the standardised therapy and the long follow-up time. We could show that the facial nerve palsy is a severe negative prognostic factor. For practical purpose, the classification into 3 histological subgroups seemed to be of great help. This should be considered in patient follow-up. Due to the amount of late recurrences, we propose a follow-up time longer than 5 years. We propose standardized surgery including total parotidectomy in combination with neck dissection. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22083860     DOI: 10.1055/s-0031-1285924

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  1 in total

1.  Clinicopathological Behavior and Oncological Outcomes of Malignant Parotid Tumors in a Pakistani Population.

Authors:  Muhammad Faisal; Taskheer Abbas; Mohammad Adeel; Usman Khaleeq; Abdul Wahid Anwer; Kashif Malik; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2018-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.